#175 A Revolution in HIV Prevention & The PURPOSE Trials: Beyond Journal Club Segment with NEJM Group

How good are we at preventing HIV? How do efficacy and effectiveness differ? We journey from oral pre-exposure prophylaxis (PrEP) to long-acting injectables , and then to the PURPOSE trials , which look at the use of long-acting lenacapavir as PrEP — a potential game-changer in the field of HIV . Listen to this latest episode of Beyond Journal Club , a collaboration between CoreIM and NEJM Group , where we put research into context , telling the story of how we arrived at the current standard of care , appreciating the clinical question of the trial at hand, and interpreting what the findings may mean for these patients . 🔹 Sponsor : NEJM Fellowship Program, click here to learn more and/or apply ! 🔹 Transcript and Show Notes Timestamps: (02:25) | HIV PrEP Daily Truvada and Descovy (07:48) | On-Demand Prep (13:25) | Purpose Trials (20:56) | Discussion of Effectiveness to Efficacy Tags: CoreIM, Internal Medicine, Primary Care, Medical Education, IMCore, Physician Assistant, Nurse Practitioner, Medical Student, HIV Prevention, Infectious Disease Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out FIGS: https://wearfigs.com * Click for 15% off Premium Starter Kit at Branch Basics: https://branchbasics.com/COREIM Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Listen